Scientists from The University of Manchester have used stem cell gene therapy to treat a fatal genetic brain disease in mice for the first time.
The method was used to treat Sanfilippo – a fatal inherited condition which causes progressive dementia in children – but could also benefit several neurological, genetic diseases.
Researchers behind the study, published in the journal Molecular Therapy this month, are now hoping to bring a treatment to trial in patients within two years.
Sanfilippo, a currently untreatable mucopolysaccharide (MPS) disease, affects one in 89,000 children in the United Kingdom, with sufferers usually dying in their mid-twenties. It is caused by the lack of SGSH enzyme in the body which helps to breakdown and recycle long chain sugars, such as heparan sulphate (HS). Children with the condition build up and store excess HS throughout their body from birth which affects their brain and results in progressive dementia and hyperactivity, followed by losing the ability to walk and swallow.
Dr Brian Bigger, from the University of Manchester’s Institute of Human Development who led the research, said bone marrow transplants had been used to correct similar HS storage diseases, such as Hurler syndrome, by transplanting normal cells with the missing enzyme but the technique did not work with Sanfilippo disease. This is because monocytes, a type of white blood cell, from the bone marrow, did not produce enough enzyme to correct the levels in the brain.
Dr Bigger said: “To increase SGSH enzyme from bone marrow transplants, and to target it to the cells that traffic into the brain, we have developed a stem cell gene therapy which overproduces the SGSH enzyme specifically in bone marrow white blood cells.
“We have shown that mice treated by this method produce five times the normal SGSH enzyme levels in the bone marrow and 11 per cent of normal levels in the brain.
“The enzyme is taken up by affected brain cells and is enough to correct brain HS storage and neuro inflammation to near normal levels and completely corrects the hyperactive behaviour in mice with Sanfilippo.
“This is extremely exciting and could have huge implications for treatments. We now hope to work to a clinical trial in Manchester in 2015.”
The University of Manchester team is now manufacturing a vector – a tool commonly used by molecular biologists to deliver genetic material into cells – for use in humans and hope to use this in a clinical trial with patients at Central Manchester University Hospital NHS Foundation Trust by 2015.
The stem cell gene therapy approach was recently shown by Italian scientists to improve conditions in patients with a similar genetic disease affecting the brain called metachromatic leukodystrophy, with results published in the journal Science earlier this month.
Manchester scientists refined the vector used by the Italian scientists. “This approach has the potential to treat several neurological genetic diseases,” Dr Bigger added.
The Latest Bing News on:
Stem cell gene therapy
- Researchers develop new method for specializing and purifying human stem cells into interneuronson February 8, 2023 at 9:00 am
Injury to the spinal cord often leads life changing disability, with decreased or complete loss of sensation and movement below the site of injury. From drugs to transplantation, there are many ...
- Cell Therapy Bioprocessing Market Projected to Reach $30M by 2028on February 8, 2023 at 7:33 am
The healthcare industry is heavily investing in developing safe and effective treatments using cell therapy technologies as an alternative to traditional treatments. The result: The cell therapy ...
- Lineage Provides Update on Auditory Neuronal Cell Transplant Program for the Treatment of Hearing Losson February 8, 2023 at 5:00 am
"ANP1 is an internally-developed program and which we believe is illustrative of the efficiency and versatility of our technology," stated Brian Culley, Lineage CEO. "In less than one year, we created ...
- IU researcher develops new therapy for treatment of ALSon February 7, 2023 at 2:10 pm
An Indiana University (IU) researcher has developed a new therapy for the treatment of ALS. IU researcher Chandler Walker, Ph.D., has developed a new stem cell-based secretome therapy. According to IU ...
- Gene Therapyon February 2, 2023 at 4:00 pm
The Cell and Gene Therapy Center will combine a team of 100 researchers to capitalize on the company’s 35 years of cell and gene therapy experience. OPGx-001 is Opus’ first program to enter clinical ...
- News - Cell and Gene Therapyon February 2, 2023 at 4:00 pm
Dutch gene therapy company uniQure and University of Massachusetts ... and acquire Editas Medicine’s pre-clinical gene edited induced pluripotent stem cell (iPSC) derived natural killer cell (iNK) ...
- Could Stem Cells Be Useful for Sports Medicine?on January 31, 2023 at 5:29 am
Stem cell therapy is a non-surgical treatment, considered the most advanced regenerative medicine for treating sports-related injuries. This type of therapy is highly effective for relieving painful ...
- What’s Holding Cell Therapies Back? A Look Into The Evolution And Future Of Stem Cell Techon January 31, 2023 at 2:46 am
While cell therapies have already come a long way, there is much to be done to streamline clinical trial submissions and approvals.
- Cell and Gene Therapy in a Nutshellon January 27, 2023 at 2:21 am
Recently, researchers have made significant progress in using stem cells to treat a wide range of conditions, including heart disease, spinal cord injuries, and diabetes. 4. Gene Therapy ...
- News tagged with stem cell geneson January 26, 2023 at 4:01 pm
A team of researchers at the University of Texas Southwestern Medical Center has found that it is possible in mice to protect the heart from ischemia-reperfusion using the CRISPR-Cas9 gene editing ...
The Latest Google Headlines on:
Stem cell gene therapy
[google_news title=”” keyword=”stem cell gene therapy” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
The Latest Bing News on:
- Iminosugars may help advance treatments for Sanfilippo: Cell studyon February 6, 2023 at 9:47 am
Treatment with sugary molecules called iminosugars can reduce the toxic buildup of heparan sulfate in cell models of Sanfilippo, a study says.
- Parkinson's Research Newson February 4, 2023 at 4:00 pm
Jan. 10, 2023 — New research says the gut microbiome is involved in multiple pathways in the pathogenesis of Parkinson's disease. The findings show a wide imbalance in microbiome composition in ...
- Newly Discovered Genetic Disease Is More Common Than Expectedon February 3, 2023 at 12:09 am
Jan. 25, 2023 – A recently discovered inflammatory disease known as VEXAS syndrome is more widespread and dangerous than previously understood, a new genetic analysis suggests. While it's rare ...
- Una ayuda para Aray, un niño que sufre síndrome de Sanfilippoon February 1, 2023 at 7:07 am
El síndrome de Sanfilippo es un trastorno metabólico de origen genético muy poco frecuente. Un cambio en un solo gen hace que el cuerpo de un niño no pueda descomponer cierto tipo de hidratos ...
- N-Substituted l-Iminosugars for the Treatment of Sanfilippo Type B Syndromeon January 25, 2023 at 7:45 pm
Department of Veterinary Medicine and Animal Productions, University of Naples Federico II, Via F. Delpino 1, 80137 Naples, Italy ...
- Resveratrol Prevents Toxic Buildup in Cells of Sanfilippo Mouse Modelon January 23, 2023 at 10:09 am
supporting further studies on this compound as a possible drug for treating Sanfilippo disease,” the researchers wrote. The study, “Activities of (Poly)phenolic Antioxidants and Other Natural ...
- Sanfilippo Syndrome Market 2023: Industry Trends, Share, Size, Growth and Forecast 2033on January 17, 2023 at 4:00 pm
Sanfilippo syndrome treatments refer to several ... of novel therapeutics and advanced medications that help to slow down disease progression and prevent complications are acting as significant ...
- Celiac Diseaseon January 10, 2023 at 6:49 pm
Celiac disease is a digestive problem that hurts your small intestine. It stops your body from taking in nutrients from food. You may have celiac disease if you are sensitive to gluten. Gluten is a ...
- First Observational Study Initiated in Sanfilippo Syndrome Type Don January 10, 2023 at 8:04 am
This study will help us further understand the course of the disease and define appropriate endpoints for our planned interventional trial," says Jill Wood, CEO of Phoenix Nest and parent of a child ...
- First Observational Study Initiated in Sanfilippo Syndrome Type Don January 10, 2023 at 6:18 am
“Natural history studies in rare diseases like Sanfilippo syndrome are a critical preparatory step to provide a baseline against which to compare outcomes in studies of new treatments. Data from ...
The Latest Google Headlines on:
[google_news title=”” keyword=”Sanfilippo disease” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]